The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7K citations · Full text

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

Pál Pacher, Takahiro Nagayama, Partha Mukhopadhyay et al. · Nature Protocols · 2008 · 713 citations · Full text

Cardiac Function, Health Sciences, Cardiac Physiology +10

Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women

Linda R. Peterson, Pilar Herrero, Kenneth B. Schechtman et al. · Circulation · 2004 · 648 citations · Full text

Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction

Kenneth B. Margulies, Adrian F. Hernandez, Margaret M. Redfield et al. · JAMA · 2016 · 635 citations · Full text

Reduced Cardiac Efficiency and Altered Substrate Metabolism Precedes the Onset of Hyperglycemia and Contractile Dysfunction in Two Mouse Models of Insulin Resistance and Obesity

Jonathan Buchanan, Pradip Kumar Mazumder, Ping Hu et al. · Endocrinology · 2005 · 542 citations · Full text

Metabolic Disorder, Contractile Dysfunction, Insulin Signaling +16